Avista is considered a long-term buy with a target price of $35.49, reflecting its undervaluation compared to sector peers and a forward price-to-earnings ratio of 13.7. The company plans to invest about $3.44 billion in infrastructure from 2026 to 2030, aiming for 4–6% growth in utility earnings. However, this growth depends on regulatory approvals and careful capital management. Risks include financing needs, potential shareholder dilution, and regulatory uncertainties that could affect cost recovery and earnings per share. The stock offers a 5.54% dividend yield, and improving utility earnings support its investment case, but future gains rely on effective execution and favorable regulatory outcomes.
Avista's valuation and growth plans provide context for readers interested in utilities. For readers following Utilities-sector US stocks on Pluang, here is the market snapshot as of Oct 13, 2026 20:33 WIB: 20 of 30 stocks rose today. Pacific Gas & Electric Co. (PCG) traded at USD 13.21 with a 1-day change of +0.38%. Consolidated Edison, Inc. (ED) was priced at USD 107.60, up +0.37%. Sempra Energy (SRE) showed a price of USD 82.14 and a Pluang order activity of 1% Sell / 99% Buy.
Domino's Pizza reported Q3 2026 earnings per share of $4.60, beating analyst expectations of $4.37, while revenue grew modestly by 3.4% to $1.19 billion. Same-store sales growth was minimal at 0.3% in the U.S. and 0.2% internationally, reflecting com...
Citigroup reported Q3 2026 earnings that exceeded analyst expectations, with EPS of $2.85 beating the $2.65 estimate and revenue of $23.8 billion slightly above forecasts. The bank's profit rose 40%, driven by exceptional fixed-income trading, invest...
State Street is set to report its Q3 2026 earnings with forecasts showing a 31.3% increase in earnings and 14% revenue growth, driven by strong net interest income and service fees. Despite record assets under management, higher operating and technol...
Restaurant Technologies, Inc. (RTI) released its 2026 Impact Report highlighting significant progress in sustainability and operational efficiency. In 2025, RTI recycled 393 million pounds of used cooking oil and delivered 719.4 million pounds of fre...
Over 60 companies are actively developing more than 65 medical marijuana therapies targeting conditions like chronic pain, neurological disorders, and cancer symptoms. Key drugs such as ZYN-002 and CardiolRx are in late-stage trials, with others in e...
